IMCR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Immunocore doses the first patient in the Phase 1 trial of IMC-S118AI, its first tissue-specific autoimmune candidate, in type 1 diabetesOct 15, 2026
- Immunocore achieved target enrollment in the registrational TEBE-AM trial of KIMMTRAK in previously treated advanced melanomaSep 14, 2026
- KIMMTRAK doubled five-year survival likelihood in first-line HLA-A*02:01-positive metastatic uveal melanoma patientsApr 20, 2026